The hvad is used for treatment not diagnosis.It was reported from (b)(6) that the patient was found non-responsive on (b)(6), 2014 with his driveline disconnected.Device testing could not be performed as the pump and driveline were not returned for evaluation.However, a review of the controller log files revealed 'driveline disconnect' alarms confirming the reported event.Log files indicate no abnormal pump operation prior to the driveline disconnect; the controller remained powered by both batteries.Review of the manufacturing documentation confirmed that the devices met all requirements for release.The post-mortem examination revealed that the patient experienced head trauma which was likely the result of the patient collapsing.The site indicated that the patient had recently experienced neurological dysfunction (hcva) which may have been a contributory factor to this event.While the cause of the driveline disconnection cannot be conclusively determined, available information indicates that the hvad system functioned as intended.There is no indication that a device malfunction caused or contributed to the reported event.The possible root cause of the patient death may have resulted from a pump stop due to the physical disconnection of the driveline cable from the controller.The ventricular assist system is indicated for use as a bridge to cardiac transplantation in patients who are at risk of death from refractory end-stage left ventricular heart failure.The system is designed for in-hospital and out-of-hospital settings.Death is a known potential clinical adverse event associated with vads as outlined in the ifu.Investigations of complaints with similar circumstances were reviewed; events related to death are multifactorial and may be attributed to failed modality, medical treatment, progression of disease, and patient comorbidities.Heartware will submit a supplemental report when new facts arises which materially alters information submitted in a previous mdr report.
|